Decoy Therapeutics awarded Chief Scientific Officer Barbara Louise Hibner 4,216 shares at $0 per share on August 31, 2026. The transaction matters to investors because it leaves Hibner with 4,216 shares, defining her reported post-award ownership in the company.

Key Highlights

  • Barbara Louise Hibner owned 4,216 Decoy Therapeutics shares after the transaction.
  • The award took place on August 31, 2026.
  • Decoy Therapeutics awarded Chief Scientific Officer Barbara Louise Hibner 4,216 shares on August 31, 2026.

Decoy Therapeutics Inc. (NASDAQ: DCOY) awarded Chief Scientific Officer Barbara Louise Hibner 4,216 shares at $0 per share. The transaction was recorded under SEC transaction code A.

Award Leaves CSO With 4,216 Shares

Hibner serves as Decoy Therapeutics’ chief scientific officer. The award date was August 31, 2026, and her reported ownership following the transaction was 4,216 shares. The consideration for the shares was $0 per share.